PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.18
ESG score 90-95% of Biotechnology median of 60.36. John Neff would demand higher returns to compensate for below-average ESG risk management.
51.62
Environmental score 90-95% of Biotechnology median of 55.08. John Neff would demand higher returns to compensate for below-average climate risk management.
58.26
Social score 90-95% of Biotechnology median of 64.22. John Neff would demand higher returns to compensate for below-average stakeholder management.
58.65
Governance score 90-95% of Biotechnology median of 62.47. John Neff would demand higher returns to compensate for below-average governance oversight.